Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Oxaliplatin and CPT-11 as First Line Treatment for Extensive Stage Small Cell Lung Cancer

NCT00316433 is registered in ClinicalTrials.gov with Swedish Medical Center as lead sponsor.

NCT NCT00316433
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00316433 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Oxaliplatin and CPT-11 as First Line Treatment for Extensive Stage Small Cell Lung Cancer
Lead sponsor
Swedish Medical Center
Phase
Phase 2
Overall status
Terminated
Start date
February 28, 2005
Completion date
January 31, 2007
Enrollment
24
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

small cell lung cancer